![]() |
市場調查報告書
商品編碼
1989058
互聯家庭健康市場預測至2034年-按產品類型、類別、組件、應用、最終用戶和地區分類的全球分析Connected Home Health Market Forecasts to 2034 - Global Analysis By Product Type, Type, Component, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球互聯家庭健康市場規模將達到 4,559 億美元,並在預測期內以 1.6% 的複合年成長率成長,到 2034 年將達到 5,206 億美元。
互聯家庭健康是一個整合了物聯網醫療設備、人工智慧遠端監測平台、遠端醫療應用和數位健康管理服務的生態系統,旨在將以往在傳統醫療機構開展的臨床級健康監測、慢性病管理和預防性健康促進服務擴展到家庭環境中。這些解決方案包括遠端患者監護設備、智慧生命徵象監測儀、連網藥物管理系統、人工智慧驅動的健康中心、虛擬護理平台和智慧跌倒偵測系統。它們透過雲端的互通性框架與醫療服務提供者持續通訊,滿足慢性疾病患者。
對個人化家庭監控的需求
在消費者對根據個人生理基準、慢性病狀況和生活方式量身定做的醫療保健體驗的需求日益成長的推動下,設備製造商、遠端醫療平台和醫療保健系統被迫投資於能夠提供真正個性化監測和干涉的互聯家庭健康解決方案。人工智慧驅動的分析平台能夠解讀長期家庭生物特徵數據,從而預測健康狀況惡化、個人化藥物依從性提醒,並根據個人反應模式調整護理通訊協定,這正在將互聯家庭健康從被動的數據收集轉變為主動的、個性化的健康管理。
醫療資料網路安全義務正在不斷擴大。
互聯家庭健康平台持續產生高度敏感的個人健康數據,包括生命徵象、用藥依從性、睡眠模式、活動數據以及慢性病生物標記,這給隱私、網路安全和合規性帶來了重大挑戰。美國部署的平台需遵守 HIPAA 法規,歐洲部署的平台需遵守 GDPR 法規,亞太地區各國還需遵守國家健康數據主權法規,這些法規都要求平台遵守複雜的合規體系,且因司法管轄區而異,從而顯著增加了平台的開發和運營成本。
老年人輔助設備市場正在迅速擴張。
旨在幫助行動不便的老年人、慢性神經系統疾病患者、認知障礙患者的看護者以及缺乏附近醫療資源的農村和低度開發地區的居民的互聯家庭健康技術,代表著一個快速成長且極具價值的商業機會。語音控制的醫療介面、人工智慧跌倒偵測系統、遠端用藥平台以及專為技術知識有限的用戶設計的智慧生命徵象監測器,正在為此前被排除在數位醫療應用之外的人群打開大門。
這家消費科技巨頭在醫療保健領域佔據主導地位
蘋果、亞馬遜、Google、三星和微軟正積極拓展其互聯健康生態系統,透過推出設備、投資健康數據平台以及與醫療服務提供者合作,充分利用其現有的消費設備滲透率和品牌信譽。這種擴張規模是任何一家互聯家庭健康公司都無法比擬的。 Apple Health、Amazon Care、Google Health 和 Samsung Health 等平台能夠產生強大的數據聚合和生態系統鎖定效應,使這些科技巨頭在互聯家庭健康領域獲得無與倫比的長期價值。獲取消費者行為數據、龐大的應用分發網路以及將健康監測功能整合到現有設備類別中的能力,構成了它們不對稱的競爭優勢。
新冠疫情加速了遠端醫療,展現了遠端患者監護在急診家庭健康領域的臨床有效性,並加速了居家診斷和虛擬醫療服務的監管核准。醫院容量的壓力促使醫療系統迅速部署出院後病患的遠距監測計畫。疫情後,消費者的就醫行為已永久轉向居家監測,而疫情期間建立的遠距遠端醫療報銷機制的擴展,為該領域的持續成長提供了強大的商業性基礎。
在預測期內,遠端患者監護(RPM)設備領域預計將佔據最大的市場佔有率。
由於遠端患者監護(RPM) 設備在為糖尿病、心臟衰竭、高血壓和慢性阻塞性肺病 (COPD) 等慢性病高風險患者群體提供傳統醫療機構之外的持續性、醫生監督的健康監測方面發揮著至關重要的心臟衰竭,預計在預測期內,RPM 設備細分市場將佔據最大的市場佔有率。美國醫療保險和醫療補助服務中心 (CMS) 擴大了遠距生理監測的報銷範圍,加上醫療系統對居家醫院和早期出院計畫的投入不斷增加,醫療服務提供者的採購需求顯著成長。廣泛的臨床適應症、完善的設備認證流程以及健康保險公司對 RPM 計畫的大力支持,共同促成了該細分市場的主導地位。
預計在預測期內,物聯網(IoMT)領域將呈現最高的複合年成長率。
在預測期內,物聯網 (IoMT) 領域預計將呈現最高的成長率,這主要得益於連網醫療設備部署的快速成長、基於雲端的醫療數據整合基礎設施以及人工智慧驅動的臨床決策支援系統的普及。這些因素共同將把分散的健康監測資料流轉化為一個連續的、可互通的醫療智慧網路。 IoMT 連接組件成本的降低、5G 網路覆蓋範圍的擴大(從而實現可靠的即時健康數據傳輸)以及電子健康記錄 (EHR)互通性標準的不斷完善,正在加速 IoMT 平台在全球醫院系統、居家醫療和消費者健康市場的應用,並推動所有主要地區實現高於平均水平的成長。
在整個預測期內,北美預計將保持最大的市場佔有率。這主要得益於高度發展的遠距遠端醫療報銷體系、消費者對穿戴式健康監測設備的廣泛接受,以及大規模的慢性疾病患者和老年人口對遠距醫療解決方案的結構性需求。美國在遠端患者監護領域處於領先地位,其醫療保險和醫療服務中心 (CMS) 的報銷代碼、醫療保健系統對家庭護理項目的大力投資以及成熟的數位健康創業生態系統都功不可沒。消費者在醫療保健技術方面的高支出以及連網監測設備保險覆蓋範圍的擴大,進一步鞏固了該地區的領先地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要得益於日本、中國、韓國和澳洲人口的快速老化,行動網路基礎設施的擴展使得遠端監測連接成為可能,以及各國政府對智慧醫療和居家養老計畫的投入不斷增加。印度遠端醫療的快速普及、中國網路醫院的擴張以及東南亞行動醫療的發展,都為互聯居家醫療的普及創造了大規模的環境。中產階級醫療費用支出的成長以及保險公司對預防性監測解決方案投入的增加,也進一步加速了該地區的成長。
According to Stratistics MRC, the Global Connected Home Health Market is accounted for $455.9 billion in 2026 and is expected to reach $520.6 billion by 2034 growing at a CAGR of 1.6% during the forecast period. Connected home health is an integrated ecosystem of IoT-enabled medical devices, AI-powered remote monitoring platforms, telehealth applications, and digital health management services that collectively extend clinical-grade health monitoring, chronic disease management, and preventive wellness capabilities from traditional healthcare facilities into the home environment. These solutions include remote patient monitoring devices, smart vital sign monitors, connected medication management systems, AI-driven health hubs, virtual care platforms, and smart fall detection systems that communicate continuously with healthcare providers through cloud-based interoperability frameworks, serving chronically ill patients, post-surgical recovery cases, aging individuals, maternal and infant health cases, and preventive wellness consumers.
Personalized Home Monitoring Demand
Escalating consumer demand for healthcare experiences tailored to individual physiological baselines, chronic disease profiles, and lifestyle patterns is compelling device manufacturers, telehealth platforms, and health systems to invest in connected home health solutions that deliver genuinely personalized monitoring and intervention. AI-powered analytics platforms capable of interpreting longitudinal home biometric data to predict deterioration events, personalize medication adherence nudges, and adapt care protocols to individual response patterns are transforming connected home health from passive data collection into active, individualized health managements
Health Data Cybersecurity Obligations Escalate
Connected home health platforms generate continuous streams of highly sensitive personal health data including vital signs, medication adherence, sleep patterns, mobility data, and chronic disease biomarkers, creating substantial privacy, cybersecurity, and regulatory compliance obligations. HIPAA requirements for US-deployed platforms, GDPR for European deployments, and national health data sovereignty regulations across Asia Pacific impose complex, jurisdiction-specific compliance architectures that significantly increase platform development and operational costs.
Elderly Assistive Care Devices Rapidly Expanding
Connected home health technologies designed to assist elderly individuals with limited mobility, patients with chronic neurological conditions, caregivers of individuals with cognitive impairment, and populations in rural or underserved communities lacking proximate healthcare access represent a rapidly expanding high-value opportunity. Voice-controlled health interfaces, AI fall detection systems, remote medication dispensing platforms, and smart vital sign monitors configured for users with limited technical literacy are unlocking demographic segments previously excluded from digital health adoption.
Consumer Tech Giants Dominate Health
Apple, Amazon, Google, Samsung, and Microsoft are aggressively expanding their connected health ecosystems through device launches, health data platform investments, and healthcare provider partnerships that leverage existing consumer device footprints and brand trust at a scale specialist connected home health companies cannot replicate. Apple Health, Amazon Care, Google Health, and Samsung Health platforms create powerful data aggregation and ecosystem lock-in effects that position these technology giants to capture disproportionate long-term connected home health value. Their access to consumer behavioral data, dominant app distribution channels, and ability to bundle health monitoring within existing device categories creates asymmetric competitive advantages.
The COVID-19 pandemic catalyzed transformational growth in connected home health by driving mass adoption of telehealth, demonstrating the clinical viability of remote patient monitoring for acute and chronic care management, and accelerating regulatory acceptance of home-based diagnostics and virtual care delivery. Hospital capacity pressures incentivized health systems to rapidly deploy remote monitoring programs for post-discharge patients. Post-pandemic health consumer behavior has permanently shifted toward home-based monitoring preferences, and expanded telehealth reimbursement frameworks established during the pandemic provide durable commercial infrastructure supporting sustained sector growth.
The remote patient monitoring (RPM) devices segment is expected to be the largest during the forecast period
The remote patient monitoring (RPM) devices segment is expected to account for the largest market share during the forecast period, due to the critical role these devices play in enabling continuous, clinician-supervised health surveillance outside of traditional care settings for high-risk patient populations managing chronic conditions including diabetes, heart failure, hypertension, and COPD. CMS reimbursement code expansion for remote physiological monitoring in the United States, combined with growing health system investment in hospital-at-home and early discharge programs, has created substantial institutional procurement demand. The breadth of clinical indications served, established device certification pathways, and strong health insurer support for RPM programs collectively underpin this segment's dominant market position.
The internet of medical things (IoMT) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the internet of medical things (IoMT) segment segment is predicted to witness the highest growth rate, driven by exponential growth of connected medical device deployments, cloud health data integration infrastructure, and AI-powered clinical decision support systems that collectively transform discrete health monitoring data streams into continuous, interoperable care intelligence networks. Falling IoMT connectivity component costs, expanding 5G network coverage enabling reliable real-time health data transmission, and deepening electronic health record interoperability standards are accelerating IoMT platform adoption across hospital systems, home health agencies, and consumer wellness markets globally, driving above-average growth across all key geographies.
During the forecast period, the North America region is expected to hold the largest market share, underpinned by a highly developed telehealth reimbursement landscape, widespread consumer adoption of wearable health monitoring devices, and a large chronically ill and aging population creating structural demand for remote care solutions. The United States leads with CMS remote patient monitoring reimbursement codes, strong health system investment in hospital-at-home programs, and a mature digital health venture ecosystem. High consumer health technology spending and growing insurer coverage of connected monitoring devices reinforce the region's dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly aging populations in Japan, China, South Korea, and Australia, expanding mobile internet infrastructure enabling remote monitoring connectivity, and growing government investment in smart healthcare and aging-in-place programs. India's telemedicine adoption surge, China's internet hospital expansion, and Southeast Asia's mobile health growth are creating large-scale connected home health deployment environments. Rising middle-class health spending and growing insurer investment in preventive monitoring solutions amplify the region's growth momentum.
Key players in the market
Some of the key players in Connected Home Health Market include Philips Healthcare, Medtronic plc, Abbott Laboratories, Omron Healthcare Co., Ltd., Fitbit, Apple Inc., Samsung Electronics Co., Ltd., Withings S.A., ResMed Inc., Dexcom Inc., iRhythm Technologies Inc., BioTelemetry Inc., Teladoc Health Inc., Amazon Care, Best Buy Health, Honeywell Life Care Solutions, GE HealthCare Technologies Inc., and Garmin Ltd.
In February 2026, Philips announced advancements in its remote patient monitoring solutions, integrating AI-driven analytics into home health devices. This update enhances early detection of chronic condition risks and supports its goal of improving the lives of 2.5 billion people annually by 2030.
In January 2026, Medtronic introduced new AI-powered diagnostic features in its connected care devices, including pulse oximeters and monitoring systems. These innovations allow real-time detection of cardiovascular and gastrointestinal conditions, strengthening its role in home-based preventive care.
In December 2025, Samsung showcased its expanded Samsung Health ecosystem, integrating virtual care, prescription management, and clinical data through its acquisition of Xealth. This move connects wellness tracking with healthcare delivery, positioning Samsung as a key player in connected home health.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.